Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2005
10/06/2005US20050221428 Chimeric neuropeptide Y receptors
10/06/2005US20050221420 Nogo receptor homologues and their use
10/06/2005US20050221368 Methods for identifying RNA binding compounds
10/06/2005US20050221355 cDNA for human methylenetetrahydrofolate reductase and uses thereof
10/06/2005US20050221317 Use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
10/06/2005US20050220900 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta
10/06/2005US20050220836 Drug delivery device
10/06/2005US20050220819 Novel binding epitopes for helicobacter pylori and use thereof
10/06/2005US20050220790 Amino-terminally truncated rantes as chemokine antagonists
10/06/2005US20050220784 Quinazoline derivatives as medicaments
10/06/2005US20050220780 Pharmaceutical composition having thrombolytic anti-inflammatory and cytoprotective properties
10/06/2005CA2561495A1 Truncated dance, dance complex and method of using these
10/06/2005CA2560927A1 Insulin resistance-improving agent
10/06/2005CA2560538A1 (r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
10/06/2005CA2560528A1 (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
10/06/2005CA2558314A1 Use of pde iii inhibitors for the reduction of heart size in mammals suffering from heart failure
10/06/2005CA2557745A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
10/05/2005EP1582586A1 Apoptosis-associated protein and use thereof
10/05/2005EP1582521A1 Fused furan compound
10/05/2005EP1582520A1 Novel parp inhibitors
10/05/2005EP1582517A1 Blood-brain barrier disruption inhibitors
10/05/2005EP1582225A2 Drug delivery device
10/05/2005EP1582215A1 Method of inhibiting cell death, cell death inhibitor and remedy for disease caused by cell death containing the cell death inhibitor
10/05/2005EP1582211A1 Jnk inhibitor
10/05/2005EP1582210A2 Compositions and methods for treating or preventing surgical adhesions
10/05/2005EP1581614A2 Nucleotide sequences for gene regulation and methods of use thereof
10/05/2005EP1581505A1 Pyridazinone derivatives as gsk-3beta inhibitors
10/05/2005EP1581308A2 Treatment of chronic heart failure
10/05/2005EP1581274A1 Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof
10/05/2005EP1581241A2 Stimulation of vascularization with vegf-b
10/05/2005EP1581239A1 Method of improvement of blood circulation
10/05/2005EP1581223A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
10/05/2005EP1581222A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-&bgr;
10/05/2005EP1516866A9 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
10/05/2005EP1419154B1 Rapamycin 29-enols
10/05/2005EP1401823B1 Substituted benzopyran derivatives against arrhythmia
10/05/2005EP1385536B1 Preparations containing a combination of vitamin e and afamin
10/05/2005EP1370271B1 A process for the manufacture of a herbal composition comprising a matrine
10/05/2005EP1368007B1 Coating and binding agent for pharmaceutical formulations with improved storage stability
10/05/2005EP1325008B1 Piperazine derivatives
10/05/2005EP1294393B1 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment and diagnosis of athersclerosis
10/05/2005EP1263430B1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
10/05/2005EP1257280B1 Pharmaceutical combination of micronised drospirenone and an estrogen for hormone replacement therapy
10/05/2005EP1233950B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
10/05/2005EP1202733B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
10/05/2005EP1197210B1 Agents inhibiting chronic rejection reactions after organ transplantation
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP1156039B1 Pyridazin-3-one derivatives and medicines containing the same
10/05/2005EP1077936B1 Novel analogs of 16-hydroxyeicosatetraenoic acid
10/05/2005CN1678626A Estrieno[3, 2-b]/[3, 4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/05/2005CN1678623A A robust, inducible cardiac preferred expression system for transgenesis
10/05/2005CN1678619A Compounds that interact with kinases
10/05/2005CN1678608A New neuropeptide y y5 receptor antagonists
10/05/2005CN1678607A Nitrogen-containing aromatic ring derivatives
10/05/2005CN1678597A Novel quaternary ammonium compounds
10/05/2005CN1678594A Morpholin-acetamide derivatives for the treatment of inflammatory diseases
10/05/2005CN1678589A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
10/05/2005CN1678583A Organic acid salt of amlodipine
10/05/2005CN1678581A Indolin phenylsulfonamide derivatives
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1678572A Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
10/05/2005CN1678524A Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
10/05/2005CN1678348A Compositions and methods for therapeutic treatment
10/05/2005CN1678347A Antibodies and uses thereof
10/05/2005CN1678334A New plant based agents as bioavailability/bioefficacy enhancers for drugs and nutraceuticals
10/05/2005CN1678332A Novel therapeutic use of polypodium extracts
10/05/2005CN1678325A Sapogenin derivatives, their synthesis and use and method based upon the use
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1678317A 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/05/2005CN1678314A Glycinamide derivatives as raf-kinase inhibitors
10/05/2005CN1678305A Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment
10/05/2005CN1676523A Method for preparing antihypertension losartan
10/05/2005CN1676520A Kuh-seng flavone extract and preparation and use thereof
10/05/2005CN1676513A Novel anti-hypertension chemical entity (TMEP)
10/05/2005CN1676508A Anti-inflammatory and anti-thrombus compound and its medicinal composition
10/05/2005CN1676161A Chinese medicine formulation for treating upper respiratory system disease, skin infection and haemorr hoids and its preparing method
10/05/2005CN1676160A Ginkgo leaf extract and dipyridamole injection formulation and its preparing process
10/05/2005CN1676152A Specific medicine of coronary disease produced from vomiting nut
10/05/2005CN1676149A Shengmai lyophilized powder for injection and its preparing method
10/05/2005CN1676141A Enteric coated capsule for treating iron-deficiency apoplexia and its preparing process
10/05/2005CN1221666C Shuttle plasmid of adenovirus and its constructing method
10/05/2005CN1221551C Aminotriazolopyridine derivatives as adenosine receptor ligands
10/05/2005CN1221546C Diphenyl azetidinone derivatives, method for prodn. thereof, medicaments contg. these compounds, and their use
10/05/2005CN1221544C Pyrazole cyclic AMP-specific PDE inhibitors
10/05/2005CN1221536C New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication
10/05/2005CN1221535C Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical preparation comprising them
10/05/2005CN1221534C Substited 8-arylquinoline phosphodiesterase-4 inhibitors
10/05/2005CN1221280C Chinese patent drug for treating heart brain blood vessel disease and its preparation method
10/05/2005CN1221278C 'Naoan' preparation for curing apoplexy and migraine and producing method
10/05/2005CN1221276C Compound Huangyangning dropping pills
10/05/2005CN1221269C Paralysis treating medicine pills
10/05/2005CN1221267C Feeze-dried powder injection contg. total saponin by refinement of American ginseng and leaves and stem of Americal ginseng, and its prodction process
10/05/2005CN1221266C Compound preparation containing alpha-linolic acid, lecithin and ginkgo flavone
10/05/2005CN1221262C Phthalazine derivatives for treating inflammatory diseases
10/05/2005CN1221261C Flunarizine hydrochloride high-capacity injecta and preparing process thereof
10/05/2005CN1221259C Preparation method of medicine for curing urteriosclerosis by using CS-866, losartan and candisartan
10/05/2005CN1221256C 药物组合物 The pharmaceutical composition of
10/05/2005CN1221252C Process for preparing slow-releasing indapamide tablet
10/04/2005US6951940 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders
10/04/2005US6951938 Aryl fused azapolycyclic compounds
1 ... 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 ... 1595